These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 34773920)

  • 21. Asian strategy for stroke prevention in atrial fibrillation.
    Chiang CE; Wang KL; Lin SJ
    Europace; 2015 Oct; 17 Suppl 2():ii31-9. PubMed ID: 26842113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stroke prevention in atrial fibrillation: a systematic review.
    Lip GY; Lane DA
    JAMA; 2015 May; 313(19):1950-62. PubMed ID: 25988464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey.
    Potpara TS; Lip GY; Larsen TB; Madrid A; Dobreanu D; Jędrzejczyk-Patej E; Dagres N;
    Europace; 2016 Oct; 18(10):1593-1598. PubMed ID: 27876696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
    Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation.
    Bisson A; Angoulvant D; Philippart R; Clementy N; Babuty D; Fauchier L
    Adv Ther; 2017 Jun; 34(6):1283-1290. PubMed ID: 28493056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor.
    Potpara TS; Dagres N; Mujović N; Vasić D; Ašanin M; Nedeljkovic M; Marin F; Fauchier L; Blomstrom-Lundqvist C; Lip GY
    Adv Ther; 2017 Feb; 34(2):357-377. PubMed ID: 27933569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Indian consensus guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulants.
    Dalal J; Bhave A; Oomman A; Vora A; Saxena A; Kahali D; Poncha F; Gambhir DS; Chaudhuri JR; Sinha N; Ray S; Iyengar SS; Banerjee S; Kaul U;
    Indian Heart J; 2015 Dec; 67 Suppl 2(Suppl 2):S13-34. PubMed ID: 26688149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy of atrial fibrillation in COVID-19 patients.
    Tomaszuk-Kazberuk A; Koziński M; Domienik-Karłowicz J; Jaguszewski M; Darocha S; Wybraniec M; Dobrowolski P; Kupczyńska K; Michalski B; Wańha W; Kapłon-Cieślicka A
    Cardiol J; 2021; 28(5):758-766. PubMed ID: 34382204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonists.
    Konieczyńska M; Sobieraj E; Bryk AH; Dębski M; Polak M; Podolec P; Małecka B; Pająk A; Desteghe L; Heidbuchel H; Undas A
    Kardiol Pol; 2018; 76(7):1089-1096. PubMed ID: 29528483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
    JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care.
    Hobbs FR; Taylor CJ; Jan Geersing G; Rutten FH; Brouwer JR;
    Eur J Prev Cardiol; 2016 Mar; 23(5):460-73. PubMed ID: 25701017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation.
    Andrade JG; Verma A; Mitchell LB; Parkash R; Leblanc K; Atzema C; Healey JS; Bell A; Cairns J; Connolly S; Cox J; Dorian P; Gladstone D; McMurtry MS; Nair GM; Pilote L; Sarrazin JF; Sharma M; Skanes A; Talajic M; Tsang T; Verma S; Wyse DG; Nattel S; Macle L;
    Can J Cardiol; 2018 Nov; 34(11):1371-1392. PubMed ID: 30404743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update and Unmet Needs on the Use of Nonvitamin K Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation.
    Menichelli D; Ettorre E; Pani A; Violi F; Pignatelli P; Pastori D
    Curr Probl Cardiol; 2021 Mar; 46(3):100410. PubMed ID: 30904157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expert consensus of the French society of geriatrics and gerontology and the French society of cardiology on the management of atrial fibrillation in elderly people].
    Hanon O; Assayag P; Belmin J; Collet JP; Emeriau JP; Fauchier L; Forette F; Friocourt P; Gentric A; Leclercq C; Komajda M; Le Heuzey JY;
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Jun; 11(2):117-43. PubMed ID: 23803629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stroke prevention in atrial fibrillation and 'real world' adherence to guidelines in the Balkan Region: The BALKAN-AF Survey.
    Potpara TS; Dan GA; Trendafilova E; Goda A; Kusljugic Z; Manola S; Music L; Musetescu R; Badila E; Mitic G; Paparisto V; Dimitrova ES; Polovina MM; Petranov SL; Djergo H; Loncar D; Bijedic A; Brusich S; Lip GY;
    Sci Rep; 2016 Feb; 6():20432. PubMed ID: 26869284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-vitamin K antagonist oral anticoagulants: new choices for patient management in atrial fibrillation.
    Saliba W
    Am J Cardiovasc Drugs; 2015 Oct; 15(5):323-35. PubMed ID: 26055615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gaps in translation from trials to practice: non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation.
    Hylek EM; Ko D; Cove CL
    Thromb Haemost; 2014 May; 111(5):783-8. PubMed ID: 24573511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation.
    Andrade JG; Aguilar M; Atzema C; Bell A; Cairns JA; Cheung CC; Cox JL; Dorian P; Gladstone DJ; Healey JS; Khairy P; Leblanc K; McMurtry MS; Mitchell LB; Nair GM; Nattel S; Parkash R; Pilote L; Sandhu RK; Sarrazin JF; Sharma M; Skanes AC; Talajic M; Tsang TSM; Verma A; Verma S; Whitlock R; Wyse DG; Macle L;
    Can J Cardiol; 2020 Dec; 36(12):1847-1948. PubMed ID: 33191198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.